The upside: FDA has begun the process of vetting the comments filed in response to its NDI Notification Guidance draft. The downside: there is no timeline for completion.
Metagenics conference stresses the importance of science as the foundation of new therapeutic foods formulated to fight against chronic illness and obesity.